Global Leukapheresis Devices Market to Surpass US$ 37.40 Million by 2027

According to Coherent Market Insights, the global leukapheresis devices market is estimated to be valued at US$ 22.32 million in 2020 and is expected to exhibit a CAGR of 7.6% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Leukapheresis Devices Market:

The global leukapheresis devices market is expected to witness significant growth, owing to increasing regulatory approval of products. For instance, in April 2020, the U.S. FDA issued emergency use authorization to Terumo BCT Inc. and Marker Therapeutics AG for their Spectra Optia Apheresis System.

Moreover, increasing prevalence of leukemia is also expected to aid in growth of the market. For instance, according to the NIH National Cancer Institute in 2015, 405,815 people were suffering from leukemia in the U.S. According to NIH estimates, the number of new cases of leukemia increased on an average rate of 0.3% each year over the last 10 years (from 2006 to 2015).

Increasing research and developments is expected to inhibit the growth of leukapheresis devices market. For instance, in May 2020, The National Heart, Lung, and Blood Institute have granted an amount of US$ 1.6 million fund to the university of Houston to execute research on the biomedical engineering. This research have been funded to adapt microfluidic technology to enable leukapheresis for the treatment of young patients. This will increase the usage of cell based therapies in young patients including pediatrics patient population as well.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4142

Key Market Takeaways:

The global leukapheresis devices market is expected to exhibit a CAGR of 7.6% during the forecast period (2020-2027), owing to increasing strategic collaborations by key players. For instance, in February 2018, Terumo BCT entered into a collaboration with Stafa Cellular Therapy. With this collaboration, Terumo BCT will act as a distributor for Stafa Cellular Therapy and will expand access to StafaCT software to healthcare organizations.

North America is expected to witness high demand for leukapheresis devices, owing to increasing prevalence and incidence of leukemia in this region. For instance, according to Leukemia and Lymphoma Society, 176,200 people in the U.S. were estimated to be diagnosed with leukemia, lymphoma or myeloma in 2019.

Competitive Landscape:

Key players operating in the global leukapheresis devices market include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, and Key Biologics, LLC.

Market Segmentation:
  • Global Leukapheresis Devices Market, By Device Type:
    • Apheresis Devices
    • Leukapheresis Columns & Cell Separators
    • Leukoreduction Filters
    • Leukapheresis Disposables
  • Global Leukapheresis Devices Market, By Application:
    • Research Applications
    • Therapeutic Applications
  • Global Leukapheresis Devices Market, By End User:
    • Hospitals
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Blood Component Providers and Blood Centers
  • Global Leukapheresis Devices Market, By Region:
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
    • Asia Pacific
      • Australia
      • India
      • China
      • Japan
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Central Africa
      • North Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com

Related Posts

Subscribe Our Newsletter